Cite
MLA Citation
U Ranganathan et al.. “PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design.” Lupus science & medicine, vol. 9, n.d., pp. A100–A101. http://access.bl.uk/ark:/81055/vdc_100167558961.0x00000b